Article Details

Hansa Biopharma Enrolls First Patient in U.S. Randomized, Controlled Pivotal Trial of ...

Retrieved on: 2021-12-29 18:22:23

Tags for this article:

Click the tags to see associated articles and topics

Hansa Biopharma Enrolls First Patient in U.S. Randomized, Controlled Pivotal Trial of .... View article details on hiswai:

Excerpt

Hansa Biopharma AB (publ) announces that the first patient in its U.S. open-label, randomized, controlled pivotal trial ("ConfIdeS") has been ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up